Health Datapalooza 2013: State of the Art - Lumeris


Published on

Health Datapalooza IV: June 3rd-4th, 2013
The State of the Art: Enterprise Data Use at the Point of Care
Janet Marchibroda, Director, Health Innovation Initiative, Bipartisan Policy Center

The new delivery models have made it clear- they need health information technology (IT) and data in order to succeed in providing high value health care. Many decision-makers and clinical staff are overwhelmed by or are looking for the evidence to support using the increasing amount and divergent types of data that can be leveraged at the enterprise level and point of care. Patient-generated data, open data streams, cost and quality information – how will it fit into the clinical workflow, and does it make a difference in operations and clinical outcomes? Join us for demos and a discussion of the state of the art.

Panel A (3:30-4:15pm): Enterprise-Level Data Analytics
Jack Challis, Chief Executive Officer & Co-Founder, CliniCast
Allen Kamer, Vice President Corporate Development and Marketing, Humedica
Jonathan Porter, Vice President Product Strategy, athenahealth
Eric Page, Chief Executive Officer, Amplify Health
Graham Gardner, Chief Executive Officer,

Panel B (4:15-5:00 pm): Data at the Point of Care
Jason Bhan, Executive Vice President & Co-founder, Medivo
Madhu Nutakki, Vice President of Digital Presence Technologies, Kaiser Permanente
Noah Craft, Chief Medical Officer, VisualDx
Michael Long, Chief Executive Officer, Lumeris
Omri Gottesman, CLIPMERGE, Mount Sinai School of Medicine

Published in: Economy & Finance, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Our success is in helping our clients achieve the Triple Aim Plus One, and ensuring every patient receives the right care, in the right setting, at the right cost; with clear accountability for clinical, financial and quality outcomes. We do this by aligning incentives, information and technology tools. There are a lot of cool apps and technology out there, but what we are finding is the best technology in the world will never get used unless there are incentives driving its usage.
  • Now, on to a patient-level view. Meet our hypothetical patient, Betty Ellis. This is her care profile within the ADSP.
  • How does the ADSP fit into the clinical workflow?At the point of care, patients like Betty Ellis are set up for a better outcome. That is because Betty’s doctor has her complete care profile on her desktop, and through our health risk assessment and enhanced encounter programs we are helping physicians see beyond their EMR/clinical data to every encounter, lab and prescription Betty has throughout the health system. One of our customers – a physician in Wisconsin - relayed the message to us that their patient feels like this system is looking out for them.
  • How does the ADSP affect cost outcomes?Several sources suggest that physicians in this country are directing approximately 80% of the heath care spend. That is why having both clinical and cost information available for physicians at the point of thought is so important – if they are to meet cost-effectiveness metrics set forth in their value-based contracts. It is estimated that nearly 30% of health care is waste in terms of unnecessary/duplicative tests. The ADSP is helping to reduce waste through effective cost utilization management.  In Betty’s case she has high blood pressure and there are a ton of medications to treat hypertension. Via the ADSP, physicians can see the brand name drug cost and the generic drug cost. Our platform brings transparency into the cost of care - not only for prescription drugs, but for all procedures and diagnostics. While each physician has about $2 million in annual spending authority, we hear from our clients all the time that physicians are in the dark about how much services cost, comparative quality and value of choices. Health systems, payers and providers have a huge opportunity to improve care through collaborative decision support and effective cost utilization and generic substitutions.
  • Health Datapalooza 2013: State of the Art - Lumeris

    1. 1. OPERATIONS • TECHNOLOGY • CONSULTINGHealth DatapaloozaData at the Point of CareJune 3, 2013
    2. 2. Proprietary and Confidential. © 2013 Lumeris, Inc.WHO WE ARE2
    3. 3. Proprietary and Confidential. © 2013 Lumeris, Inc.SHIFT TO RISK3Accountable Care and The Shift To Risk
    4. 4. Proprietary and Confidential. © 2013 Lumeris, Inc.WHAT WE DO4• Cloud-Based Enterprise IT• 22 ACO Core Competencies• 1,000+ Man-Years Invested• 70% of Clinicians and Hospitals• Multi-Payer• 300M Annual Transactions• Innovation and Best Practices• Provider Transformation• 4.5 star rated MAPD plan• 61% MCR (before incentives)• # 1 plan in marketProofPlatformConnectivityTransformation
    5. 5. Proprietary and Confidential. © 2013 Lumeris, Inc.THE RIGHT CARE,in the Right Setting,at the Right CostWITH CLEAR ACCOUNTABILITY FORClinical, Financial, andQuality OutcomesPopulationHealthManagementLower PerCapita CostsPhysicianSatisfactionEnhancedPatientExperienceTripleAim*+ 1Ensuring every patient receives…5LUMERIS’ SUCCESS
    6. 6. Proprietary and Confidential. © 2013 Lumeris, Inc.Support the Transition to Population ManagementTECHNOLOGY TOOLS6
    7. 7. Proprietary and Confidential. © 2013 Lumeris, Inc. 7
    8. 8. Proprietary and Confidential. © 2013 Lumeris, Inc.PATIENT CARE PROFILE8
    9. 9. Proprietary and Confidential. © 2013 Lumeris, Inc. 9CLINICAL WORKFLOW
    10. 10. Proprietary and Confidential. © 2013 Lumeris, Inc. 10CLINICAL OUTCOMES
    11. 11. Proprietary and Confidential. © 2013 Lumeris, Inc. 11COST OUTCOMES
    12. 12. Proprietary and Confidential. © 2013 Lumeris, Inc. 12PHYSICIAN SATISFACTION
    13. 13. Proprietary and Confidential. © 2013 Lumeris, Inc. 13PATIENT SATISFACTION
    14. 14. Proprietary and Confidential. © 2013 Lumeris, Inc.CONNECT WITH LUMERIS14